MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
Citius Pharmaceuticals, Inc (NASDAQ: CTXR)*
Organization & Developments: Citius Pharmaceuticals
Parents
Citius Pharmaceuticals, Inc (NASDAQ: CTXR)*
Children
CITI-002, which provides anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids
CITI-101, which is a bio-absorbable film impregnated with minocycline and rifampin for reducing acute inflammation and microbial colonization of breast tissue expanders used in breast reconstruction surgeries following mastectomies.
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.
It is currently advancing three proprietary product candidates:
Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections
Jumps
Finance & Acquisitions: Citius Pharmaceuticals
Key People: Citius Pharmaceuticals